Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3162-3214

Bentham Science Publishers

Access to resources Recommend Favorite

Non-carboxylic antiinflammatory compounds. III. N-(4,6-Dimethylpyridin-2-yl)arylcarboxamides and arylthiocarboxamides acting as brain edema inhibitors

By Robert J.   Robert-Piessard S.   Courant J.   Le Baut G.   Robert B.   Lang F.   Petit J.   Grimaud N.   Welin L.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 12, 1995-01 ,pp. : 915-924

Elsevier

Access to resources Recommend Favorite

Synthesis and evaluation of novel fluorinated sulotroban-related sulfonamide derivatives as thromboxane A 2 receptor antagonists

By Sato M.   Kawashima Y.   Goto J.   Yamane Y.   Chiba Y.   Jinno S.   Satake M.   Iwata C.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 5, 1995-01 ,pp. : 403-414

Elsevier

Access to resources Recommend Favorite

Selective CCR2B receptor antagonists based on indole-2-carboxylic acid

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 145-148

Informa Healthcare

Access to resources Recommend Favorite

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors

By Michaux C.   Dogne J.-M.   Rolin S.   Masereel B.   Wouters J.   Durant F.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 7, 2003-07 ,pp. : 703-710

Elsevier

Access to resources Recommend Favorite